Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_assertion type Assertion NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_head.
- NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_assertion description "[Inoculation of streptozotocin (STZ)-treated mice with vCVB(dm)GLP-1 was found to suppress development of hyperglycemia and increase insulin production relative to mice treated with STZ alone or with empty vector.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_provenance.
- NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_assertion evidence source_evidence_literature NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_provenance.
- NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_assertion SIO_000772 21937637 NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_provenance.
- NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_assertion wasDerivedFrom befree-2016 NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_provenance.
- NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_assertion wasGeneratedBy ECO_0000203 NP925506.RARCl5ELxqpvMzbE-B1HpTCGFgKcuW0zPcxdOY0EjVeB0130_provenance.